Effectiveness of early cancer screening and diagnosis in urban China
- PMID: 40595801
- PMCID: PMC12215646
- DOI: 10.1038/s41598-025-05020-1
Effectiveness of early cancer screening and diagnosis in urban China
Abstract
Early cancer screening is globally acknowledged as a key strategy for reducing cancer mortality and improving treatment efficacy, and has been integrated into core public health policies in many countries. To assess the effectiveness of early cancer screening programs in China and to inform targeted screening strategies for high-risk populations, we examined trends in screening adherence and detection rates for five cancers among individuals aged 40-74 in Nanchang, China. From 2018 to 2022, we used the Cancer Risk Assessment Questionnaire to evaluate cancer risk, referring high-risk individuals to designated hospitals for free clinical screenings by appointment. During this period, 75,554 participants were assessed. The results revealed an overall high-risk rate of 54.12%, with no significant gender difference (53.86% for men and 54.29% for women). The highest risk rate, 61.88%, was observed in the 65-69 age group. Among the cancers studied, lung cancer had the highest risk (29.54%), followed by colorectal (26.02%), upper gastrointestinal (21.40%), breast (20.22%), and liver cancer (11.58%). Notably, all cancer types except breast cancer had higher risk rates in men. The participation rate for breast cancer screening was the highest, followed by those for lung cancer, liver cancer, colorectal cancer, and upper gastrointestinal cancer. As the program progressed, we observed a decrease in the overall high-risk rate and an increase in screening adherence for lung and colorectal cancers. Future efforts should focus on improving screening and monitoring risk factors for the 65-69 age group. Additionally, enhancing awareness campaigns for lung cancer, refining screening methods for upper gastrointestinal cancers, and increasing participation in screening programs are crucial.
Keywords: Cancer; Clinical screening; Early screening and diagnosis; Risk assessment; Urban.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethical approval: This study has undergone review by the Ethics Committee of Jiangxi Cancer Hospital, China. The research complies with scientific and ethical principles, with subject risks maintained within manageable limits, and no conflicts of interest identified. The Ethics Committee has approved the initiation of the study. Consent to participate: Informed consent was obtained from all subjects involved in the study according to the recommendations of the Board of Ethics of each participating center. Competing interests: The authors declare no competing interests.
Figures
Similar articles
-
Interventions targeted at women to encourage the uptake of cervical screening.Cochrane Database Syst Rev. 2021 Sep 6;9(9):CD002834. doi: 10.1002/14651858.CD002834.pub3. Cochrane Database Syst Rev. 2021. PMID: 34694000 Free PMC article.
-
Selenium for preventing cancer.Cochrane Database Syst Rev. 2018 Jan 29;1(1):CD005195. doi: 10.1002/14651858.CD005195.pub4. Cochrane Database Syst Rev. 2018. PMID: 29376219 Free PMC article.
-
Impact of low-dose computed tomography (LDCT) screening on lung cancer-related mortality.Cochrane Database Syst Rev. 2022 Aug 3;8(8):CD013829. doi: 10.1002/14651858.CD013829.pub2. Cochrane Database Syst Rev. 2022. PMID: 35921047 Free PMC article.
-
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2. Cochrane Database Syst Rev. 2022. PMID: 36161421 Free PMC article.
-
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340. Health Technol Assess. 2006. PMID: 16959170
References
-
- Sung, H. et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA A Cancer J. Clin.71(3), 209–249 (2021). - PubMed
-
- Chen, W. et al. Cancer statistics in China, 2015. CA A Cancer J. Clin.66(2), 115–132 (2016). - PubMed
-
- Sroczynski, G. et al. Long-term benefits and harms of early colorectal cancer screening in German individuals with familial cancer risk. Int J. Cancer154(3), 516–529 (2024). - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials